111 related articles for article (PubMed ID: 11036198)
41. Cyclosporin A, FK506 and rapamycin produce multiple, temporally distinct, effects on memory following single-trial, passive avoidance training in the chick.
Bennett PC; Schmidt L; Lawen A; Moutsoulas P; Ng KT
Brain Res; 2002 Feb; 927(2):180-94. PubMed ID: 11821011
[TBL] [Abstract][Full Text] [Related]
42. The neuronal choline transporter CHT1 is regulated by immunosuppressor-sensitive pathways.
Guermonprez L; O'Regan S; Meunier FM; Morot-Gaudry-Talarmain Y
J Neurochem; 2002 Aug; 82(4):874-84. PubMed ID: 12358793
[TBL] [Abstract][Full Text] [Related]
43. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat.
Yoshimoto T; Uchino H; He QP; Li PA; Siesjö BK
Brain Res; 2001 Apr; 899(1-2):148-58. PubMed ID: 11311876
[TBL] [Abstract][Full Text] [Related]
44. A role for calcineurin in degranulation of murine cytotoxic T lymphocytes.
Dutz JP; Fruman DA; Burakoff SJ; Bierer BE
J Immunol; 1993 Apr; 150(7):2591-8. PubMed ID: 7681074
[TBL] [Abstract][Full Text] [Related]
45. Effect of cyclosporine, tacrolimus and sirolimus on cellular senescence in renal epithelial cells.
Koppelstaetter C; Kern G; Leierer G; Mair SM; Mayer G; Leierer J
Toxicol In Vitro; 2018 Apr; 48():86-92. PubMed ID: 29309803
[TBL] [Abstract][Full Text] [Related]
46. Short- and long-term differential effects of neuroprotective drug NS-7 on voltage-dependent sodium channels in adrenal chromaffin cells.
Yokoo H; Shiraishi S; Kobayashi H; Yanagita T; Minami S; Yamamoto R; Wada A
Br J Pharmacol; 2000 Oct; 131(4):779-87. PubMed ID: 11030728
[TBL] [Abstract][Full Text] [Related]
47. Cyclosporin A produces distal renal tubular acidosis by blocking peptidyl prolyl cis-trans isomerase activity of cyclophilin.
Watanabe S; Tsuruoka S; Vijayakumar S; Fischer G; Zhang Y; Fujimura A; Al-Awqati Q; Schwartz GJ
Am J Physiol Renal Physiol; 2005 Jan; 288(1):F40-7. PubMed ID: 15353404
[TBL] [Abstract][Full Text] [Related]
48. Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture.
Wera S; Zheng L; Hooghe-Peters EL; Belayew A; Martial JA; Velkeniers B
Endocr Res; 1995 Aug; 21(3):623-33. PubMed ID: 7588431
[TBL] [Abstract][Full Text] [Related]
49. Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents.
Pereira MJ; Palming J; Rizell M; Aureliano M; Carvalho E; Svensson MK; Eriksson JW
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1885-94. PubMed ID: 25004245
[TBL] [Abstract][Full Text] [Related]
50. Modulation of Na+-Ca2+ exchanger expression by immunosuppressive drugs is isoform-specific.
Elbaz B; Alperovitch A; Gottesman MM; Kimchi-Sarfaty C; Rahamimoff H
Mol Pharmacol; 2008 Apr; 73(4):1254-63. PubMed ID: 18182482
[TBL] [Abstract][Full Text] [Related]
51. Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitary corticotrope tumor cells.
Pompeo A; Baldassare M; Luini A; Buccione R
Life Sci; 1999; 64(10):837-46. PubMed ID: 10096434
[TBL] [Abstract][Full Text] [Related]
52. Transcriptional up-regulation of cell surface Na V 1.7 sodium channels by insulin-like growth factor-1 via inhibition of glycogen synthase kinase-3β in adrenal chromaffin cells: enhancement of 22Na+ influx, 45Ca2+ influx and catecholamine secretion.
Yanagita T; Satoh S; Uezono Y; Matsuo K; Nemoto T; Maruta T; Yoshikawa N; Iwakiri T; Minami K; Murakami M
Neuropharmacology; 2011 Dec; 61(8):1265-74. PubMed ID: 21816165
[TBL] [Abstract][Full Text] [Related]
53. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
[TBL] [Abstract][Full Text] [Related]
54. Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible.
Parat MO; Fox PL
J Biol Chem; 2001 May; 276(19):15776-82. PubMed ID: 11278313
[TBL] [Abstract][Full Text] [Related]
55. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
56. Tacrolimus causes a blockage of protein secretion which reinforces its immunosuppressive activity and also explains some of its toxic side-effects.
Rauch MC; San Martín A; Ojeda D; Quezada C; Salas M; Cárcamo JG; Yañez AJ; Slebe JC; Claude A
Transpl Immunol; 2009 Dec; 22(1-2):72-81. PubMed ID: 19628039
[TBL] [Abstract][Full Text] [Related]
57. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures.
Igarashi K; Hirotani H; Woo JT; Stern PH
Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740
[TBL] [Abstract][Full Text] [Related]
58. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation.
Deppe CE; Heering PJ; Viengchareun S; Grabensee B; Farman N; Lombès M
Endocrinology; 2002 May; 143(5):1932-41. PubMed ID: 11956176
[TBL] [Abstract][Full Text] [Related]
59. Substitution in position 3 of cyclosporin A abolishes the cyclophilin-mediated gain-of-function mechanism but not immunosuppression.
Baumgrass R; Zhang Y; Erdmann F; Thiel A; Weiwad M; Radbruch A; Fischer G
J Biol Chem; 2004 Jan; 279(4):2470-9. PubMed ID: 14583619
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of T cell cAMP formation by cyclosporin A and FK506.
Ockenfels HM; Wagner SN; Oeljeklaus P; Schneck B; Nussbaum G; Jakobs KH; Goos M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):513-6. PubMed ID: 8740144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
